Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
about
Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges AheadPrognostic significance of MYC, BCL2, and BCL6 rearrangements in patients with diffuse large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone plus rituximabMature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphomaThe effects of DLEU1 gene expression in Burkitt lymphoma (BL): potential mechanism of chemoimmunotherapy resistance in BLAn increased frequency of 13q deletions detected by fluorescence in situ hybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children's Oncology Group study CCG-5961.Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report.Clinical outcome of relapsed or refractory burkitt lymphoma and mature B-cell lymphoblastic leukemia in children and adolescents.Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trialMinimal disease assessment in the treatment of children and adolescents with intermediate-risk (Stage III/IV) B-cell non-Hodgkin lymphoma: a children's oncology group report.A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.Genome wide copy number analysis of paediatric Burkitt lymphoma using formalin-fixed tissues reveals a subset with gain of chromosome 13q and corresponding miRNA over expressionMolecular distinctions between pediatric and adult mature B-cell non-Hodgkin lymphomas identified through genomic profilingClinical course and prognostic factors of children with Burkitt's lymphoma in a developing country: the experience of a single centre in BrazilClinicopathological Analysis of B Cell Lymphomas, Unclassifiable; with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma in a Tertiary Care Hospital in Southern IndiaSocioeconomic Factors Impact Inpatient Mortality in Pediatric Lymphoma Patients.The Prognostic Significance of the Serum p53 Protein Concentration in Chinese Patients with Non-Hodgkin Lymphoma.Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q: A Case ReportRisk factors and treatment of childhood and adolescent Burkitt lymphoma/leukaemia.Mature B-cell lymphoma and leukemia in children and adolescents-review of standard chemotherapy regimen and perspectives.Biomarkers in childhood non-Hodgkin's lymphomas.MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas.Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG).Conventional and molecular cytogenetic characterization of Burkitt lymphoma with bone marrow involvement in Brazilian children and adolescents.Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations.Comparative genomic expression signatures of signal transduction pathways and targets in paediatric Burkitt lymphoma: a Children's Oncology Group report.Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma.Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.Adolescent and young adult non-Hodgkin lymphoma.Comprehensive cytogenetic and molecular cytogenetic analysis of 44 Burkitt lymphoma cell lines: secondary chromosomal changes characterization, karyotypic evolution, and comparison with primary samples.Cell-of-origin classification by gene expression and MYC-rearrangements in diffuse large B-cell lymphoma of children and adolescents.Survival predictors of Burkitt's lymphoma in children, adults and elderly in the United States during 2000-2013.The next step for Burkitt lymphomaOutcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia.Chromosome abnormalities in diffuse large B-cell lymphomas: analysis of 231 Chinese patients.MYC Gene Rearrangements Are Closely Associated with Poor Survival of Diffuse Large B Cell Lymphoma with Hepatitis B Virus Infection.Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.The clinicopathologic spectrum of mature aggressive B cell lymphomas.TP53 pathway analysis in paediatric Burkitt lymphoma reveals increased MDM4 expression as the only TP53 pathway abnormality detected in a subset of cases.Genetic differences between paediatric and adult Burkitt lymphomas.
P2860
Q26797513-25539C80-8415-4DF7-B753-64D5F980346CQ28256567-CBF58EBA-BCCA-49C2-82AE-738123A5F33BQ30240133-66FD7ED1-8260-432C-A642-5AC46727595EQ30873773-D4B01D80-4211-4F9F-B216-1EFDBEF31ADFQ33709463-4AAC9448-2C7D-44F4-8C48-5A56E3C37A9AQ34020070-F47E21D4-8831-41EB-9070-B6BCBD9413ADQ34344942-E5BDAD93-2AC6-4DFF-83AF-77E5A4A3D6E4Q34386029-19DB6D3F-25B0-44B1-B988-B10FDA345839Q34737471-533EDFD2-79F0-499B-B83F-687DADB29AB7Q35011933-6C461D52-739D-4406-A527-182EFE35EB3AQ35084573-51735512-4AAC-4ED3-9866-02E7C0ACFCA6Q35476235-383C5F72-EFE8-4607-8B55-6444209EA7D0Q35909668-9F8EF101-8F77-41B2-87B4-3646A0943BFFQ36364844-60F78560-EEB2-4002-A034-53C2C51311A2Q36679590-FBC74BE4-4F80-40CE-8B06-8CEA805A9013Q37069880-0C2E448A-2F69-4491-BA88-7F66A16511C2Q37193859-A3588325-3021-4B95-96B0-365182E5941BQ37206989-AE63F3F7-8969-4757-A13C-2D6EF01603B9Q37977133-373A831A-08E1-4D6F-9C0D-EBBBD0D74E2DQ38097544-D63ACCF9-6DBD-44B1-959B-E5AC4F973034Q38138608-C0F8EA89-3DD1-42FB-A0CC-6692C369461DQ38147318-D288EE87-F327-459E-8C32-C07432847948Q38384014-588555F6-4FAE-4957-99C2-04F2DECA6B27Q38421466-48F9CE67-63A5-4410-8B83-73D5331ADDF6Q38536238-940DB521-DEC6-43EF-80F2-DC596B4DC683Q38687541-008CCB1F-EB2A-4946-94F1-FA45CE4A7E1FQ38771110-9F45EE4A-7258-43D2-ACD7-9294886B4746Q38782141-7E5F4051-6159-4BDA-B9F2-9D373563E96AQ38806478-19EE3A1A-53C6-4974-8137-9F5D2A33AC6FQ39018921-AE2E00D7-0506-4410-A0DC-F64C75E8A88AQ39393429-2B01413D-4CBD-423A-B93C-249EDA7EBFD0Q40411469-D478282A-5EC6-43BC-8E06-5E33C9879E70Q42785005-5DD1A0BD-77F5-49A9-8388-C6961403270AQ44198884-BB95A8B0-34A3-42DE-AF5B-82B5BADA7978Q45010726-C36A82F0-4035-4678-8469-35F3CFC1657DQ45323747-003A1618-50D5-47B3-814D-6F28F4475F63Q46125111-DB4DDBEE-5065-4681-8DB4-9BDAB9B123CFQ48170832-65E9302D-3CDB-43D2-81F8-12B9B6A010D7Q52628104-B1F23781-E7ED-4A47-BFBA-C1F04B0B31B3Q53174284-EB7E082B-6EA0-4F73-9D1E-F609CA577194
P2860
Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@ast
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@en
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@nl
type
label
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@ast
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@en
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@nl
prefLabel
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@ast
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@en
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@nl
P2093
P2860
P356
P1433
P1476
Specific cytogenetic abnormali ...... AB/LMB 96 international study.
@en
P2093
A Bernheim
FAB/LMB 96 International Study Committee
H A Poirel
J Swansbury
K McCarthy
P2860
P2888
P304
P356
10.1038/LEU.2008.312
P577
2008-11-20T00:00:00Z
P5875
P6179
1001624988